Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Discovery of Macrocyclic Inhibitors of Apurinic/Apyrimidinic Endonuclease 1

Journal Article · · Journal of Medicinal Chemistry
 [1];  [2];  [3];  [3];  [4];  [4];  [5];  [1];  [1];  [2];  [1];  [4];  [6]
  1. Boston Univ., MA (United States). Center for Molecular Discovery (BU-CMD)
  2. Boston Univ., MA (United States)
  3. Indiana Univ., Indianapolis, IN (United States). School of Medicine
  4. Indiana Univ., Indianapolis, IN (United States). School of Medicine, Herman B. Wells Center for Pediatric Research
  5. Boston Univ., MA (United States). Center for Molecular Discovery (BU-CMD); Emory Univ., Atlanta, GA (United States)
  6. Indiana Univ., Indianapolis, IN (United States). School of Medicine; Purdue Univ., Indianapolis, IN (United States). Purdue School of Science

Apurinic/apyrimidinic endonuclease 1 (APE1) is an essential base excision repair enzyme that is upregulated in a number of cancers, contributes to resistance of tumors treated with DNA-alkylating or -oxidizing agents, and has recently been identified as an important therapeutic target. Here in this work, we identified hot spots for binding of small organic molecules experimentally in high resolution crystal structures of APE1 and computationally through the use of FTMAP analysis (http://ftmap.bu.edu/). Guided by these hot spots, a library of drug-like macrocycles was docked and then screened for inhibition of APE1 endonuclease activity. In an iterative process, hot-spot-guided docking, characterization of inhibition of APE1 endonuclease, and cytotoxicity of cancer cells were used to design next generation macrocycles. To assess target selectivity in cells, selected macrocycles were analyzed for modulation of DNA damage. Taken together, our studies suggest that macrocycles represent a promising class of compounds for inhibition of APE1 in cancer cells.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
National Institutes of Health (NIH); Earl and Betty Herr Professor in Pediatric Oncology Research; Jeff Gordon Children’s Foundation; Riley Children’s Foundation; USDOE
OSTI ID:
1502255
Journal Information:
Journal of Medicinal Chemistry, Journal Name: Journal of Medicinal Chemistry Journal Issue: 4 Vol. 62; ISSN 0022-2623
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
ENGLISH

References (43)

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility journal December 2009
Apurinic/apyrimidinic endonuclease 1 (APE1/Ref-1) overexpression is an independent prognostic marker in prostate cancer withoutTMPRSS2:ERGfusion journal May 2017
Small molecule inhibitors of DNA repair nuclease activities of APE1 journal August 2010
Mechanisms of bacterial resistance to macrolide antibiotics journal January 1999
What can a chemist learn from nature?s macrocycles? ? A brief, conceptual view journal January 2005
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
Rule of five in 2015 and beyond: Target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions journal June 2016
Lead- and drug-like compounds: the rule-of-five revolution journal December 2004
Knockdown of the DNA repair and redox signaling protein Ape1/Ref-1 blocks ovarian cancer cell and tumor growth journal February 2008
The value of nature's natural product library for the discovery of New Chemical Entities: The discovery of ingenol mebutate journal October 2014
Evolution of the redox function in mammalian apurinic/apyrimidinic endonuclease journal August 2008
Mechanism and Diversity of the Erythromycin Esterase Family of Enzymes journal February 2012
High-Resolution Crystal Structures Reveal Plasticity in the Metal Binding Site of Apurinic/Apyrimidinic Endonuclease I journal October 2014
Synthesis of a Library of Complex Macrodiolides Employing Cyclodimerization of Hydroxy Esters journal July 2005
Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery journal April 2011
Synthesis, Biological Evaluation, and Structure–Activity Relationships of a Novel Class of Apurinic/Apyrimidinic Endonuclease 1 Inhibitors journal March 2012
Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties? journal September 2013
DNA Repair and Redox Activities and Inhibitors of Apurinic/Apyrimidinic Endonuclease 1/Redox Effector Factor 1 (APE1/Ref-1): A Comparative Analysis and Their Scope and Limitations toward Anticancer Drug Development journal October 2014
Pharmacophore Guided Discovery of Small-Molecule Human Apurinic/Apyrimidinic Endonuclease 1 Inhibitors journal December 2008
Bifunctional Homoallylic Carbamates from Chiral Silane Additions to in Situ Generated N-Acyl Iminium Ions journal June 2012
DNA-bound structures and mutants reveal abasic DNA binding by APE1 DNA repair and coordination journal January 2000
How proteins bind macrocycles journal July 2014
Tools and rules for macrocycles journal July 2014
The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins journal April 2015
The exploration of macrocycles for drug discovery — an underexploited structural class journal July 2008
Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic journal June 2017
Development and evaluation of human AP endonuclease inhibitors in melanoma and glioma cell lines journal January 2011
Efficient inhibition of human AP endonuclease 1 (APE1) via substrate masking by abasic site-binding macrocyclic ligands journal January 2015
Human Apurinic/Apyrimidinic Endonuclease 1 journal February 2014
Fragment-based identification of druggable ‘hot spots’ of proteins using Fourier domain correlation techniques journal January 2009
FTSite: high accuracy detection of ligand binding sites on unbound protein structures journal November 2011
Recommendations for conducting the in vivo alkaline Comet assay journal January 2003
Isolation of a small molecule inhibitor of DNA base excision repair journal August 2005
The expression profile and prognostic value of APE/Ref-1 and NPM1 in high-grade serous ovarian adenocarcinoma journal August 2017
Novel Small-Molecule Inhibitor of Apurinic/Apyrimidinic Endonuclease 1 Blocks Proliferation and Reduces Viability of Glioblastoma Cells journal May 2010
Potent Inhibition of Human Apurinic/Apyrimidinic Endonuclease 1 by Arylstibonic Acids journal November 2007
Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models journal November 2016
Abstract B158: Targeting APE1/Ref-1 results in inhibition of hypoxia signaling genes journal December 2015
The expression of APE1 in triple-negative breast cancer and its effect on drug sensitivity of olaparib journal October 2017
Identification and Characterization of Inhibitors of Human Apurinic/apyrimidinic Endonuclease APE1 journal June 2009
The Comet Assay for DNA Damage and Repair: Principles, Applications, and Limitations journal January 2004
APE1 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis journal August 2017
Macrocyclic Drugs and Synthetic Methodologies toward Macrocycles journal May 2013

Similar Records

DNA Apurinic-Apyrimidinic Site Binding And Excision By Endonuclease IV
Journal Article · Mon May 18 00:00:00 EDT 2009 · Nature Struct. Biol 15:515,2008 · OSTI ID:953156

Apurinic/apyrimidinic endonucleases in repair of pyrimidine dimers and other lesions in DNA
Journal Article · Fri Aug 01 00:00:00 EDT 1980 · Proc. Natl. Acad. Sci. U.S.A.; (United States) · OSTI ID:6946390

Conserved structural chemistry for incision activity in structurally non-homologous apurinic/apyrimidinic endonuclease APE1 and endonuclease IV DNA repair enzymes.
Journal Article · Fri Mar 22 00:00:00 EDT 2013 · Journal of Biological Chemistry · OSTI ID:1170766